Project Grant R21AR084632
- Summary The University of Arkansas, Fayetteville is conducting fundamental biomedical research on skeletal muscle aging and rejuvenation under a $141,890 Project Grant (R01) awarded by the National Institute on Aging through its Aging Research program (CFDA 93.866). The project, spanning from June 1, 2025 through July 31, 2030, investigates the role of the MYC transcription factor in mediating muscle functional, metabolic, cellular, and molecular plasticity across the lifespan. Researchers...
- The University of Florida, through its Division of Sponsored Research, received a $1.83 million Project Grant award dated September 5, 2025, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports a three-year research project through August 31, 2028, investigating the role of NADPH oxidases (NOX) in sepsis-induced myopathy and impaired muscle regeneration. The...
- This Project Grant, awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports fundamental research into the epigenetic control of tissue regeneration across multiple species and developmental stages. The research project, funded at $435,875 and performed by Vanderbilt University's Sponsored Programs Administration in Nashville, Tennessee, will generate scientific knowledge regarding how gene...
- This five-year, $649,659 National Science Foundation Engineering Project Grant will support research at the Massachusetts Institute of Technology to advance fundamental understanding of the tissues that produce voluntary movement in humans and other biological creatures. Specifically, the grant will fund experiments studying how mechanical signaling coordinates assembly, maturation and repair at the neuromuscular interface in both physiological and pathological states. The principal investigator...
- Federal Project Grant Award Summary Columbia University's Health Sciences Division received a $660,613 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective June 1, 2026 through March 31, 2031. The research focuses on developing and validating spinal cord stimulation (SCS) as a combination therapy to enhance motor function in patients with...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $540,322 Project Grant to The Ohio State University (Office of Sponsored Programs) on August 1, 2025, under CFDA 93.853 (Extramural Research Programs in the Neurosciences and Neurological Disorders). This research initiative investigates the role of three-dimensional chromatin architecture, specifically topologically associating domains (TADs) and enhancer-promoter interactions, in regulating axonal regeneration...
- Federal Project Grant Award Summary San Jose State University Research Foundation received a $183,125 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025 through July 31, 2029. The award funds fundamental biomedical research investigating the mechanisms by which diet regulates muscle stem cell (MUSC) activation and proliferation in Drosophila models. The research...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded Kenyon College a Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $454,424 grant, effective April 1, 2025 through March 31, 2028, aims to characterize the cellular and molecular mechanisms of Schwann cell demyelination and identify factors that promote peripheral remyelination using a novel larval zebrafish model. The project will test...
- Grant Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Salk Institute for Biological Studies a $3.003 million Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) effective August 1, 2025, through June 30, 2030. This multi-investigator collaborative award funds research to characterize spinal neural circuit function during motor control in awake behaving mice using nano-electronic...
- This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to investigate the functional roles of microRNA-320 (miR-320) in skeletal muscle. The $374,204 award to The Leland Stanford Junior University will fully characterize a muscle-specific miR-320 knockout mouse model, examine the underlying mechanisms of the observed muscle wasting...
REGULATION OF MUSCLE STEM CELLS BY NETRIN SIGNALING - SKELETAL MUSCLE REGENERATES FOLLOWING INJURY, WITH MUSCLE STEM CELLS (MUSCS) THE SOURCE OF NEW MYOFIBERS. MUSCS ARE QUIESCENT DURING HOMEOSTASIS. QUIESCENCE IS AN ACTIVELY MAINTAINED STATE, SUPPORTED BY SIGNALS FROM THE MUSC NICHE. UPON MUSCLE INJURY, MUSCS ACTIVATE AND ENTER THE CELL CYCLE, PROLIFERATE AS MYOBLASTS, AND DIFFERENTIATE AND FUSE TO FORM NEW MYOFIBERS. HOW MUSCS MAINTAIN QUIESCENCE IS NOT WELL UNDERSTOOD, AND THERE IS LITTLE KNOWN ABOUT THE EARLIEST EVENTS IN THE TRANSITION FROM QUIESCENCE TO ACTIVATION (THE Q-A TRANSITION). QUIESCENT MUSCS IN VIVO HAVE LONG, HETEROGENEOUS CELLULAR PROJECTIONS THAT RAPIDLY RETRACT IN RESPONSE TO MUSCLE INJURY. PROJECTIONS MAY THEREFORE ACT AS DIRECT SENSORS OF THE NICHE ENVIRONMENT. PROJECTION RETRACTION IS DRIVEN BY A RAC-TO-RHO GTPASE ACTIVITY SWITCH THAT PROMOTES DOWNSTREAM MUSC ACTIVATION EVENTS. THESE OBSERVATIONS LEAD TO SEVERAL HYPOTHESES: 1) MUSC PROJECTIONS ARE MORPHOLOGICALLY DYNAMIC AT QUIESCENCE, PROVIDING A SURVEILLANCE FUNCTION FOR MUSCLE DAMAGE; 2) MUSC DYNAMICS DURING QUIESCENCE ARE REGULATED BY THE RELATIVE BALANCE OF RAC AND RHO ACTIVITIES PROMOTED BY NICHE-DERIVED CUES; AND 3) THERE EXIST FACTORS IN MUSCLE TISSUE THAT SIGNAL TO STIMULATE MUSC PROJECTION OUTGROWTH AND, CONSEQUENTLY, PROMOTE MUSC QUIESCENCE. SUCH FACTORS ARE ANTICIPATED TO BE CRITICAL REGULATORS OF MUSC QUIESCENCE AND THE Q-A TRANSITION, BUT THEIR IDENTITIES ARE UNKNOWN. MOREOVER, NEW APPROACHES ARE REQUIRED TO SCREEN FOR CANDIDATE FACTORS. WE HAVE DEVELOPED AN EX VIVO LIVE IMAGING ASSAY FOR MUSCS WITHIN MUSCLE BUNDLES AND USED IT TO IDENTIFY THE AXONAL CHEMOATTRACTANT, NETRIN-1, AS A CANDIDATE NICHE-DERIVED REGULATOR OF MUSC PROJECTION DYNAMICS. MULTIPLE CELL TYPES IN ADULT MUSCLE EXPRESS NETRIN-1, AND MUSCS EXPRESS THE NETRIN-1 RECEPTORS, NEOGENIN (NEO1) AND DCC. FURTHERMORE, MUSCS EXTEND PROJECTIONS IN RESPONSE TO RECOMBINANT NETRIN-1, AS VISUALIZED IN THE EX VIVO LIVE IMAGING ASSAY. IT IS PROPOSED HERE TO DETERMINE THE ROLE OF NETRIN-1 SIGNALING IN MUSC QUIESCENCE AND THE Q-A TRANSITION. WE WILL USE CONDITIONAL GENETIC REMOVAL OF NETRIN-1 RECEPTORS FROM MUSCS TO TEST DIRECTLY THE ROLE OF NETRIN-1 SIGNALING IN MUSC MORPHOLOGY, QUIESCENCE, AND THE Q-A TRANSITION. A COMBINATION OF IN VIVO AND EX VIVO TECHNIQUES WILL BE USED, INCLUDING TISSUE CLEARING, IN VIVO ANALYSES OF UNINJURED AND INJURED MUSCLES, ANALYSIS OF MUSCS ON SINGLE MYOFIBERS; AND LIVE IMAGING OF MUSCS WITHIN MUSCLE BUNDLES. SUCCESSFUL COMPLETION OF THE PROPOSED WORK WILL PROVIDE STRONG EVIDENCE THAT: 1) REGULATION OF MUSC PROJECTION DYNAMICS IS A KEY PROCESS IN MAINTENANCE OF QUIESCENCE; AND 2) NETRIN-1 IS THE FIRST MEMBER OF A NEW CLASS OF MUSC QUIESCENCE REGULATOR. SUCH FINDINGS WILL VALIDATE THE USE OF OUR NEW EX VIVO LIVE IMAGING ASSAY AS A MEANS TO IDENTIFY SECRETED SIGNALING CUES INVOLVED IN THIS PROCESS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $180.3k | 5/6/25 | ||
| Not listed | $223.1k | 7/23/24 | ||
| Not listed | $223.1k | 7/23/24 |